Inventor · disambiguated record
Charles Decedue
Also filed as: DECEDUE CHARLES · DECEDUE CHARLES J
14 granted patents·10 pending applications·44 citations·filing 2014–2024
90Inventor score
Files withCRITITECH INC24
Top patents by PatentIndex Score
24 records- 0196US10391090B2Methods for solid tumor treatmentCRITITECH INC·Filed 2018·Granted Aug 27, 2019·16 cites·26 claims
- 0295US10894045B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jan 19, 2021·11 cites·22 claims
- 0395US10874660B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Dec 29, 2020·10 cites·20 claims
- 0489US11033542B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jun 15, 2021·2 cites·24 claims
- 0586US12329858B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 0684US11458133B2Methods for solid tumor treatmentCRITITECH INC·Filed 2020·Granted Oct 4, 2022·1 cites·22 claims
- 0784US11058639B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2020·Granted Jul 13, 2021·1 cites·24 claims
- 0884US9925512B2Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2015·Granted Mar 27, 2018·3 cites·22 claims
- 0983US12128131B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·18 claims
- 1082US12390459B2Methods for solid tumor treatmentCRITITECH INC·Filed 2022·Granted Aug 19, 2025·0 cites·20 claims
- 1180US11918691B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2023·Granted Mar 5, 2024·0 cites·14 claims
- 1280US11737972B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·18 claims
- 1374US11583499B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2021·Granted Feb 21, 2023·0 cites·21 claims
- 1473US11523983B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 1570US2019254957A1Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 1670US2022096423A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2021·Application pending·0 cites
- 1767US2019209515A1Treatment of Bladder Cancer by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 1867US2019209514A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 1961US2021214683A1Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2058US2018221849A1Equipment Assembly for and Method of Processing ParticlesCRITITECH INC·Filed 2018·Application pending·0 cites
- 2156US2015342872A1Use of Paclitaxel ParticlesCRITITECH INC·Filed 2014·Application pending·0 cites
- 2251US2019365700A1Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer VaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2344US2019365699A1Treatment of Kidney Tumors by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2444US2019365698A1Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of CancerCRITITECH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Decedue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →